ClearChoice dental implant centers will integrate Planmeca technology to boost its digital imaging capabilities for patients.
Dental implant group ClearChoice has announced that it is partnering with Planmeca and Henry Schein. More specifically, ClearChoice Management Services (CCMS) will partner with Planmeca to boost dental implant patient experiences with advanced digital imaging technology. ClearChoice doctors at more than 75 centers across the U.S. will integrate the cone-beam computed tomography (CBCT) imaging unit Viso®G7 among other digital imaging technologies.
With this partnership, dental professionals will be able to use CBCT and intraoral scans to create treatment plans for dental implant patients. The partnership was a good match, according to Planmeca USA President Glen Kendrick.
“The combination of superior image quality, smooth workflow and ease of use made the Planmeca Viso G7 the perfect choice for ClearChoice,” Kendrick said in a press release from ClearChoice. “Many of the innovative features of the Viso G7 fit ClearChoice’s patient-centric approach, including Ultra Low Dose™ imaging protocols and Planmeca CALM, a proprietary patient movement correction algorithm. Innovative technology coupled with our dedication to continuous and ongoing education of both clinicians and staff, Planmeca is ready to partner with ClearChoice to provide a high-quality and seamless experience for a complex dental procedure.”
This Planmeca integration will also include Romexis®, ProSensor®HD, and Planmeca ProX™.